Asset Details
Do you wish to reserve the book?
NOX4 functions as a mitochondrial energetic sensor coupling cancer metabolic reprogramming to drug resistance
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
NOX4 functions as a mitochondrial energetic sensor coupling cancer metabolic reprogramming to drug resistance
Do you wish to request the book?
NOX4 functions as a mitochondrial energetic sensor coupling cancer metabolic reprogramming to drug resistance
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
NOX4 functions as a mitochondrial energetic sensor coupling cancer metabolic reprogramming to drug resistance
2017
Overview
The molecular mechanisms that couple glycolysis to cancer drug resistance remain unclear. Here we identify an ATP-binding motif within the NADPH oxidase isoform, NOX4, and show that ATP directly binds and negatively regulates NOX4 activity. We find that NOX4 localizes to the inner mitochondria membrane and that subcellular redistribution of ATP levels from the mitochondria act as an allosteric switch to activate NOX4. We provide evidence that NOX4-derived reactive oxygen species (ROS) inhibits P300/CBP-associated factor (PCAF)-dependent acetylation and lysosomal degradation of the pyruvate kinase-M2 isoform (PKM2). Finally, we show that NOX4 silencing, through PKM2, sensitizes cultured and ex vivo freshly isolated human-renal carcinoma cells to drug-induced cell death in xenograft models and ex vivo cultures. These findings highlight yet unidentified insights into the molecular events driving cancer evasive resistance and suggest modulation of ATP levels together with cytotoxic drugs could overcome drug-resistance in glycolytic cancers.
NADPH oxidase NOX4 has been linked to poor cancer survival. Here the authors show that NOX4 regulates drug resistance in renal cancer carcinoma by regulating PKM2 and that NOX4 activity is allosterically activated by reduced mitochondrial ATP levels thus coupling energy metabolism to drug resistance.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ Animals
/ Antineoplastic Agents, Phytogenic - pharmacology
/ Cancer
/ Carcinoma, Renal Cell - drug therapy
/ Carcinoma, Renal Cell - metabolism
/ Carcinoma, Renal Cell - pathology
/ Carrier Proteins - metabolism
/ Energy Metabolism - drug effects
/ Energy Metabolism - physiology
/ Humanities and Social Sciences
/ Humans
/ Kidney Neoplasms - drug therapy
/ Kidney Neoplasms - metabolism
/ Kidney Neoplasms - pathology
/ Male
/ Membrane Proteins - metabolism
/ Mice
/ NADPH Oxidase 4 - metabolism
/ Oxidase
/ p300-CBP Transcription Factors - metabolism
/ Reactive Oxygen Species - metabolism
/ Science
/ Thyroid Hormone-Binding Proteins
/ Thyroid Hormones - metabolism
